Innovation

Novel peptides to promote wound healing and neuroprotection

Children's Hospital Boston
posted on 04/29/2010

Drs. D'Amato and Adini tested synthetic short peptides from a well-known membrane bound protein. They found that a 12-mer peptide derived from the extracellular domain was able to dramatically stimulate VEGF binding to endothelial cells, to enhance cell proliferation in vitro, and cell migration and angiogenesis in vivo. This peptide promoted wound healing by 50% over control in the diabetic mouse wound healing model. Interestingly, the peptide also increased neurite outgrowth in primary cortical neuronal cells. Drs. D'Amato and Adini are currently exploring various peptide designs to further optimize activity and are expanding testing to other in vivo models of wound healing and neurodegeneration.


Innovation Details
 

File Number: CMCC 1691 

Other Information: *Investigator(s)*
Robert D'Amato

*Contact*
Maude Tessier, Maude.Tessier@childrens.harvard.edu


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact David Altman at Children's Hospital Boston for more information.

Request more info via email request more info
People

Case Manager:

David Altman David Altman

Innovations (0)


Download Technology Brief (PDF)


Followed By
Organization
Profile
Related Tags

Find more innovations


February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...